Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG)
Clinical trial NCT03624946 · COMPLETED
Trial details
- NCT number
- NCT03624946
- Sponsor
- Emergent BioSolutions
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-27
- Primary completion
- 2019-03-06
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.